Mobile Navigation

Subscribe for the Newsletter

Drug Discovery

1 / 10
Enhanced Genomics
Alzheimer's

Enhanced Genomics and The ALBORADA Drug Discovery Institute Partner to Accelerate Alzheimer's Drug Discovery

Enhanced Genomics

PR-06-25-NI-08Jun 24, 2025
Beyond the Proteasome: Unlocking New Frontiers with AUTACs and LYTACs
Degradation

Beyond the Proteasome: Unlocking New Frontiers with AUTACs and LYTACs

David Alvaro, Ph.D.

Pharma's Almanac

PAO-06-25-NI-01Jun 02, 2025
Designer Control: DREADDs and the Next Generation of Targeted Neuromodulation
Neuroscience

Designer Control: DREADDs and the Next Generation of Targeted Neuromodulation

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-25-NI-11May 29, 2025
Therapeutic Nanobodies and Intrabodies Rewriting the Rules of Target Engagement
Nanobodies

Therapeutic Nanobodies and Intrabodies Rewriting the Rules of Target Engagement

David Alvaro, Ph.D.

Pharma's Almanac

PAO-05-25-NI-10May 27, 2025
Spintronics and the Future of Drug Design
Spintronics

Spintronics and the Future of Drug Design

David Alvaro, Ph.D.

Pharma's Almanac

PAO-04-25-NI-03Apr 04, 2025
Magnetogenetics and the Future of Remote Biological Control
Magnetogenetics

Magnetogenetics and the Future of Remote Biological Control

David Alvaro, Ph.D.

Pharma's Almanac

PAO-03-25-NI-04Mar 17, 2025
Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors
Bispecifics

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Gardiner Smith; Reiner Gentz, Ph.D.

Fab Biopharma

PR-09-24-NI-19Sep 27, 2024
Transforming Drug Development through a Female Perspective
Female-Centric

Transforming Drug Development through a Female Perspective

Chia Chia Sun; William Freimuth, Ph.D., M.D.

Fab Biopharma

PAO-09-24-CL-03Sep 10, 2024
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Developability

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Heonchang Lim

Samsung Biologics

PAO-09-24-CL-04Sep 04, 2024
PROTACS: Upgrading Small Molecule Inhibitors
Protein Degradation

PROTACS: Upgrading Small Molecule Inhibitors

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-06-24-NI-02Jun 11, 2024
Small Molecule API Discovery and Development Trends
Nice Insight API Report

Small Molecule API Discovery and Development Trends

April Stanley, MS MBA

Nice Insight

PAO-03-24-NI-01Mar 21, 2024
Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights
Genomics

Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-01-24-NI-03Jan 30, 2024
The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond
Molecular Machines

The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-01-24-NI-02Jan 22, 2024
Piramal Pharma Solutions
In Vitro Biology

Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Piramal Pharma Solutions

PR-M10-23-04Oct 17, 2023
Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine
3D Cell Culture

Unleashing the Power of 3D Cell Culture: Revolutionizing Research, Drug Discovery, and Biomedicine

Elizabeth Abraham, Ph.D.; Catherine Siler, Ph.D.

Corning Life Sciences

PAO-09-23-CL-02Sep 29, 2023
Integrating Digital Solutions to Streamline Biopharma Operations
R&D

Integrating Digital Solutions to Streamline Biopharma Operations

Christian Olsen

Dotmatics

PAO-07-23-CL-06Jul 17, 2023
Addressing Cancer Therapy Resistance by Targeting Translational Regulation
Oncology

Addressing Cancer Therapy Resistance by Targeting Translational Regulation

Steve Worland, Ph.D.

eFFECTOR

PAO-06-23-CL-02Jun 01, 2023
Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat
Generative AI

Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat

Petrina Kamya, Ph.D.

Insilico Medicine

PAO-04-23-CL-02Apr 13, 2023
Targeted Protein Degradation Provides Promising Alternative to Address Unmet Medical Needs
Targeted Protein Degradation

Targeted Protein Degradation Provides Promising Alternative to Address Unmet Medical Needs

Henrik Daub, Ph.D.

NEOsphere Biotechnologies GmbH

PAO-03-23-CL-07Mar 30, 2023
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
Tumor Microenvironment

Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies

Gil Efron

Purple Biotech

PAO-03-23-CL-01Mar 21, 2023
1 / 10